Tonic-clonic seizures

Clinical trials for Tonic-clonic seizures explained in plain language.

Never miss a new study

Get alerted when new Tonic-clonic seizures trials appear

Sign up with your email to follow new studies for Tonic-clonic seizures, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New epilepsy drug XEN1101 tested for long-term seizure control

Disease control By invitation only

This study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …

Matched conditions: TONIC-CLONIC SEIZURES

Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Tonic-clonic seizures

Get alerted when new Tonic-clonic seizures trials appear

New epilepsy drug XEN1101 tested for long-term seizure control